Complement and Invariant NKT Cell Response
Lead Research Organisation:
UNIVERSITY OF OXFORD
Department Name: Weatherall Inst of Molecular Medicine
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
People |
ORCID iD |
| Nazish Malik (Student) |
Studentship Projects
| Project Reference | Relationship | Related To | Start | End | Student Name |
|---|---|---|---|---|---|
| BB/P50435X/1 | 30/09/2016 | 30/03/2021 | |||
| 1808605 | Studentship | BB/P50435X/1 | 30/09/2016 | 30/03/2021 | Nazish Malik |
| Description | GSK collaboration |
| Organisation | GlaxoSmithKline (GSK) |
| Country | Global |
| Sector | Private |
| PI Contribution | I have generated different cell types from whole blood, and assessed activation profiles following addition of GSK compounds described in the next section. |
| Collaborator Contribution | GSK have provided expertise in complement, along with access to small-molecule inhibitors along with antibodies that target distinct complement signalling pathways. |
| Impact | This collaboration is relatively new and as such there are no outputs/ outcomes to report as yet. |
| Start Year | 2018 |